Evidence map›Paper›PMID 27660216›Full record

ReviewJournal of molecular neuroscience : MN2016

Delivery of Fluorescent Nanoparticles to the Brain.

Olga Shimoni, Bingyang Shi, Paul A Adlard, Ashley I Bush

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular neuroscience : MN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olga ShimoniSchool of Mathematical and Physical Sciences, University of Technology Sydney, P.O. Box 123, Broadway, Sydney, NSW, 2007, Australia. olga.shimoni@uts.edu.au.ORCID http://orcid.org/0000-0001-8822-1024
Bingyang ShiDepartment of Biomedical Science, Faculty of Medicine and Health Science, Macquarie University, Sydney, NSW, 2109, Australia.
Paul A AdlardThe Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.
Ashley I BushThe Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology applications in neuroscience promises to deliver significant scientific and technological breakthroughs, providing answers to unresolved questions regarding the processes occurring in the brain. In this perspective, we provide a short background on two distinct fluorescent nanoparticles and summarize several studies focussed on achieving delivery of these into the brain and their interaction with brain tissue. Furthermore, we discuss challenges and opportunities for further development of nanoparticle-based therapies for targeting delivery of drugs across the blood-brain barrier.

Indexed as

NanodiamondsAnimalsBlood-Brain BarrierDrug Delivery SystemsFluorescent DyesHumansLuminescent ProteinsNeuroimagingFluorescent DyesLuminescent ProteinsNanodiamondsBlood-brain barrierFluorescent nanoparticlesMultifunctional nanoparticlesNanodiamondsUpconversion nanoparticles

Identifiers

PMID27660216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.